Concepedia

J. O’Shaughnessy

JO

Statistics

Publications

1

Citations

11

H-Index

1

Active since

2024

Affiliations

Champalimaud Foundation(Current)

J. O’Shaughnessy is an author at Champalimaud Foundation specializing in neoadjuvant hormonal therapy, her2-positive breast cancer therapy, and neoadjuvant therapy.

Publications per year

2024–2024

1

Publications

1

Neoadjuvant pembrolizumab or placebo + chemotherapy, followed by adjuvant pembrolizumab or placebo plus endocrine therapy for early-stage high-risk ER+/HER2– breast cancer: Results from the phase 3 KEYNOTE-756 study

Fátima Cardoso, J. O’Shaughnessy, Heather L. McArthur et al. · European Journal of Cancer · 2024 · 11 citations · Full text

, , +17

1–1 of 1